4DMedical Limited (ASX:4DX)
3.340
-0.150 (-4.30%)
May 28, 2026, 4:10 PM AEST
4DMedical Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, 4DMedical stock has a consensus rating of "Hold" and an average price target of $4.47. The average 1-year stock price forecast is 33.83% higher than the current stock price, while the lowest is $3.00 (-10.18%) and the highest is $5.90 (+76.65%).
Price Target: $4.47 (+33.83%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 23, 2026.
Analyst Ratings
The average analyst rating for 4DMedical stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 1 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Downgrades $5.90 | Hold | Downgrades | $5.90 | +76.65% | Apr 23, 2026 |
| Ord Minnett | Ord Minnett | Sell Maintains $3.20 → $3.00 | Sell | Maintains | $3.20 → $3.00 | -10.18% | Mar 24, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $2.50 → $4.50 | Buy | Maintains | $2.50 → $4.50 | +34.73% | Feb 3, 2026 |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.